• Revenues down 26% to $2.82 million
• Loss up 1201% to $3.61 million
• Obtained 100% control of Neuro Elite Athletics

Control Bionics Limited has reported its financial results for the half-year ended 31 December 2025. Revenues from ordinary activities declined by 26% to $2,820,044, while the loss from ordinary activities after tax attributable to the owners of the company increased by 1201% to $3,609,172. The company noted that there were no dividends paid, recommended or declared during the half-year period. The net tangible assets per ordinary security increased from 0.49 cents to 0.73 cents. During the period, the company obtained 100% control of Neuro Elite Athletics, LLC, increasing its interest from 20.71% to 100%. However, as control was obtained on 31 December 2025, there was no material contribution to the Group's loss for the period. The financial statements were subject to a review by the auditors, who noted a material uncertainty relating to the Group's ability to continue as a going concern.